Literature DB >> 6967515

Immune disease and HLA associations with myasthenia gravis.

P O Behan.   

Abstract

In the late 1950's laboratory and clinical evidence suggested that myasthenia gravis was an autoimmune disorder. Since then a voluminous literature has developed documenting the many immunological abnormalities that occur in this condition. Recent findings point to a central disorder of immunoregulation. It is postulated that the disease occurs as a result of host genetic and environmental influences-the latter being, as yet unidentified and possibly a virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967515      PMCID: PMC490628          DOI: 10.1136/jnnp.43.7.611

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  82 in total

1.  MYASTHENIA GRAVIS AND HYPERTHYROIDISM IN TWO SISTERS.

Authors:  J GREENBERG
Journal:  Arch Neurol       Date:  1964-08

2.  Myasthenia gravis in one monozygotic twin.

Authors:  M ALTER; O R TALBERT
Journal:  Neurology       Date:  1960-08       Impact factor: 9.910

3.  HLA antigens and myasthenia gravis in Japan.

Authors:  T Yoshida; M Tsuchiya; A Ono; H Yoshimatsu; E Satoyoshi; K Tsuji
Journal:  J Neurol Sci       Date:  1977-06       Impact factor: 3.181

4.  Congenital myasthenia gravis in twins. Identical twins with crises in the newborn period.

Authors:  W T McLean; R C McKone
Journal:  Arch Neurol       Date:  1973-10

5.  HL-A frequencies in patients with myasthenia gravis.

Authors:  J Säfwenberg; J B Lindblom; P O Osterman
Journal:  Tissue Antigens       Date:  1973

6.  Letter: Rosette tests following thymectomy.

Authors:  G P Sandilands; K Gray; A Cooney; J R Anderson; J A Simpson; P O Behan
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

7.  Lymphocyte function in myasthenia gravis.

Authors:  S Kawanami; A Kanaide; Y Itoyama; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-08       Impact factor: 10.154

8.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Familial early infantile myasthenia gravis.

Authors:  B BORNSTEIN
Journal:  Acta Paediatr       Date:  1953-09       Impact factor: 2.299

10.  HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis.

Authors:  J Säfwenberg; L Hammarström; J B Lindblom; G Matell; E Möller; P O Osterman; C I Smith
Journal:  Tissue Antigens       Date:  1978-08
View more
  8 in total

1.  Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis.

Authors:  R Mantegazza; D Pareyson; F Baggi; P Romagnoli; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  Ital J Neurol Sci       Date:  1988-04

2.  A case of myasthenia gravis associated with optic neuritis.

Authors:  A Ghezzi; M Zaffaroni; D Caputo; A Zibetti; G Mariani
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

3.  Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.

Authors:  W M Behan; P O Behan; D Doyle
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  HLA antigens and myasthenia gravis in north India.

Authors:  N K Mehra; G K Ahuja; V Taneja; M C Vaidya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-04       Impact factor: 10.154

5.  Myasthenia gravis associated with adrenocortical insufficiency. Report of two cases.

Authors:  P Dumas; F Archambeaud-Mouveroux; J M Vallat; D Barussaud; J Hugon; M Dumas
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

6.  Myasthenia gravis and Schmidt syndrome.

Authors:  J K McAlpine; J E Thomson
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

7.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

8.  Familial myasthenia gravis.

Authors:  D Honeybourne; P A Dyer; P D Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.